Related Experiment Video
Updated: May 18, 2026

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples
Published on: October 2, 2020
New insights into signalling networks regulating breast cancer stem cells
Abstract:
In a recent paper, Aceto and colleagues report that Src homology 2 domain-containing protein tyrosine phosphatase 2 (Shp2) plays a critical role in maintenance of breast tumour-initiating cells, and they define novel effectors downstream of Shp2 that regulate cellular invasion and self-renewal, including the transcription factors c-Myc and zinc finger E-box binding homeobox 1 and the suppressor of miRNA biogenesis lin-28 homolog B. These findings provide important mechanistic insights into breast tumourigenesis and highlight Shp2 as a potential therapeutic target.
Insights
Src homology 2 domain-containing protein tyrosine phosphatase 2 (Shp2) is crucial for breast tumor-initiating cells. New downstream effectors regulate invasion and self-renewal, offering therapeutic targets for breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Breast tumor-initiating cells (BTICs) are critical for tumor recurrence and metastasis.
- The role of specific signaling pathways in BTIC maintenance remains incompletely understood.
Purpose of the Study:
- To investigate the role of Src homology 2 domain-containing protein tyrosine phosphatase 2 (Shp2) in maintaining breast tumor-initiating cells.
- To identify novel downstream effectors of Shp2 that regulate BTIC functions.
Main Methods:
- Utilized molecular biology techniques to study Shp2 signaling in breast cancer models.
- Investigated the function of identified downstream targets in cellular invasion and self-renewal assays.
Main Results:
- Shp2 is essential for the maintenance of breast tumor-initiating cells.
- Identified c-Myc, ZEB1, and LIN28B as novel downstream effectors regulated by Shp2.
- These effectors modulate cellular invasion and self-renewal capabilities.
Conclusions:
- Shp2 signaling is a key regulator of breast tumor-initiating cell biology.
- Targeting Shp2 or its downstream effectors may offer a novel therapeutic strategy for breast cancer.
Related Concept Videos
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

